Average Co-Inventor Count = 5.89
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Takeda Pharmaceutical Company Limited (16 from 1,179 patents)
2. Takeda San Diego, Inc. (5 from 53 patents)
3. Biophysica, Inc. (4 from 9 patents)
4. Millennium Pharmaceuticals Limited (3 from 850 patents)
5. Other (1 from 832,843 patents)
29 patents:
1. 11560434 - Formulation for anti-α4β7 antibody
2. 10738046 - Substituted pyrido[3,4-b]pyrazines as GPR6 modulators
3. 10407409 - 6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
4. 10406157 - Tetrahydropyridopyrazine modulators of GPR6
5. 10273225 - Pyrazines as modulators of GPR6
6. 10077266 - Substituted pyrido[3,4-b]pyrazines as GPR6 modulators
7. 10040855 - Formulation for anti-α4β7 antibody
8. 10000468 - Pyrazines as modulators of GPR6
9. 9944626 - 6-(5-hydroxy-1H-pyrazol-1-YL)nicotinamide inhibitors of PHD
10. 9764033 - Formulation for anti-α4β7 antibody
11. 9708296 - 6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
12. 9708313 - Substituted pyrido[3,4-b]pyrazines as GPR6 modulators
13. 9345713 - 6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
14. 9181249 - Substituted pyrido[3,4-b]pyrazines as GPR6 modulators
15. 9040522 - 6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD